Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
TKNO | US
0.10
2.00%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
19/09/2024
5.11
5.21
5.39
5.03
Alpha Teknova Inc. produces critical reagents for the research discovery development and commercialization of novel therapies vaccines and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation resuspension and purification. It serves life sciences market including pharmaceutical and biotechnology companies contract development and manufacturing organizations in vitro diagnostic franchises and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister California.
View LessPositive Momentum
Strength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
76.6%1 month
75.8%3 months
140.5%6 months
116.6%-
-
2.97
0.39
0.27
-6.23
7.07
-
-23.44M
272.38M
272.38M
-
-53.05
-
-16.60
-41.51
0.98
1.25
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.39
Range1M
1.46
Range3M
4.30
Rel. volume
1.35
Price X volume
1.26M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
ESSA Pharma Inc | EPIX | Drug Manufacturers-Specialty & Generic | 6.48 | 287.51M | 7.11% | n/a | 0.27% |
Cipher Pharmaceuticals Inc | CPHRF | Drug Manufacturers-Specialty & Generic | 11.03 | 284.72M | -3.50% | 12.74 | 0.00% |
Procaps Group S.A. Ordinary Shares | PROC | Drug Manufacturers-Specialty & Generic | 1.8 | 203.08M | -0.55% | 3.63 | 0.00% |
Galectin Therapeutics Inc | GALT | Drug Manufacturers-Specialty & Generic | 2.84 | 176.87M | 4.80% | n/a | -113.78% |
LFCR | LFCR | Drug Manufacturers-Specialty & Generic | 5.62 | 173.65M | 8.08% | 20.72 | 241.85% |
CRDL | CRDL | Drug Manufacturers-Specialty & Generic | 2.25 | 157.36M | 2.27% | n/a | 1.07% |
Zomedica Pharmaceuticals Corp | ZOM | Drug Manufacturers-Specialty & Generic | 0.13 | 129.73M | 1.96% | n/a | 1.10% |
Assertio Therapeutics Inc | ASRT | Drug Manufacturers-Specialty & Generic | 1.35 | 128.70M | 3.85% | n/a | 30.76% |
Aceto Corporation | ACET | Drug Manufacturers-Specialty & Generic | 1.52 | 125.25M | 4.11% | n/a | 8.14% |
OptiNose Inc | OPTN | Drug Manufacturers-Specialty & Generic | 0.7956 | 119.96M | -6.40% | n/a | -294.40% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.5 | 236.20M | -2.49% | 9.50 | 39.79% |
Unifi Inc | UFI | Textile Manufacturing | 7.59 | 138.98M | 6.60% | n/a | 52.56% |
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 37.9 | 107.64M | -1.76% | 5.90 | 15.58% |
Culp Inc | CULP | Textile Manufacturing | 6.35 | 79.31M | 5.31% | n/a | 11.29% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 5.78 | 62.58M | -6.47% | n/a | 54.96% |
ILAG | ILAG | Building Products & Equipment | 1.04 | 18.78M | 13.06% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.02 | 12.43M | -7.27% | n/a | 16.03% |
The Dixie Group Inc | DXYN | Textile Manufacturing | 0.737 | 11.34M | 3.80% | n/a | 422.08% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.6475 | 6.16M | -2.76% | n/a | 19.98% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.315 | 4.97M | -1.56% | n/a | 0.97% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -6.23 | 16.67 | Cheaper |
Ent. to Revenue | 7.07 | 309.37 | Cheaper |
PE Ratio | - | 29.14 | - |
Price to Book | 2.97 | 12.81 | Cheaper |
Dividend Yield | - | 2.80 | - |
Std. Deviation (3M) | 140.53 | 75.12 | Riskier |
Debt to Equity | 0.39 | -0.93 | Expensive |
Debt to Assets | 0.27 | 0.45 | Cheaper |
Market Cap | 272.38M | 5.22B | Emerging |